C43 C44
Conditions
Interventions
Group 1: The measuring head of the fluorescence scanner is fixed on the skin lesion to be examined on the patient.
The lesion will be examined more than 20 minutes with a laser power of up to 50mW (be
Sponsors
Otto-von-Guericke Universität MagdeburgMedizinische Fakultät
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Adults 18-80 years 2. clinical suspicion of an epithelial, melanocytic or mesenchymal tumor as basal cell carcinoma, Porom, Pinkus tumor, seborrheic keratosis, Melanoakantom, actinic keratosis grade I-III, squamous cell carcinoma, naevoid lentigo, Nevus, dysplastic nevus, early invasive melanoma, Merkel cell carcinoma, pleomorphic sarcoma or Dermatofibrosarkoma protuberans etc. 3. written consent after verbal intelligence
Exclusion criteria
Exclusion criteria: 1. lack of capacity to consent 2. Pregnancy and lactation 3. poor general condition (ECOC 3-4) 4. serious bacterial and mycotic infection 5. tumors in face localization or to the scalp
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Is by "VertiSCAN" a sufficiently reliable in-vivo diagnosis of skin tumors possible a. significantly correlated with the results of the subsequent examination of the tissue sample b. and thus a tissue sample makes dispensable, at least in certain cases. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Is by "VertiSCAN" a sufficiently reliable ex-vivo diagnosis of skin tumors possible a. significantly correlated with the results of the subsequent histological examination of the tissue sample b. and the section diagnosis "on side" 2. obtain clinical information about ergonomics in hospital use, in order to create through technical improvements to the machine a clinically optimal usable diagnostic tool | — |
Countries
Germany
Contacts
Public ContactDaniela Göppner
Klinik für Dermatologie und Allergologie, UKGM Unikliniken Gießen/Marburg, Standort Gießen
Outcome results
None listed